.
RMED financial statements
* Numbers in thousands
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
67 564 | 31 025 | 11 196 | 697 |
EV * |
4 099 | 16 999 | -10 445 | -10 445 |
Stock price $ |
183 | 59 | 6.59 | 0.41 |
Number of shares * |
369 | 526 | 1 699 | 1 699 |
EPS |
-83,51 | -108,32 | -21,22 | -21,22 |
Revenue * |
6 257 | 7 199 | 4 405 | 4 405 |
Net income * |
-30 832 | -56 957 | -36 045 | -36 045 |
Operating profit * |
-31 160 | -57 730 | -36 059 | -36 059 |
Total liabilities * |
7 330 | 10 931 | 12 291 | 12 291 |
Net debt * |
-63 465 | -14 026 | -21 641 | -21 641 |
Total assets * |
74 035 | 44 081 | 33 438 | 33 438 |
Equity * |
66 705 | 33 150 | 21 147 | 21 147 |
Cash and investments * |
64 315 | 30 577 | 23 906 | 23 906 |
Over the past 10 years, the maximum capitalization of Ra Medical Systems Inc is 67 564, the minimum is 11 196. Maximum net income 0, Minimum net income -56 957. The maximum price of RMED shares is 183, the minimum price is 6.59.
.
RMED valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
-2,19 | -0,54 | -0,31 | -0,02 |
P/B |
1,01 | 0,94 | 0,53 | 0,03 |
P/S |
10,80 | 4,31 | 2,54 | 0,16 |
E/P |
-46% | -184% | -322% | -5 175% |
P/FCF |
-3,54 | -0,93 | -0,39 | -0,02 |
.
RMED profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-46% | -172% | -170% | |
ROA |
-42% | -129% | -108% | |
ROIC |
-46% | -155% | -140% |